

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cholesterol biosynthetic process (GO:0006695) | 7.21712925 |
| 2 | fatty acid elongation (GO:0030497) | 6.78895887 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.67584984 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.67584984 |
| 5 | * sterol biosynthetic process (GO:0016126) | 6.31698318 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.20419851 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.20419851 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68618975 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.54184750 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.44034489 |
| 11 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.99059017 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.88736171 |
| 13 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.87439741 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.86385141 |
| 15 | isoprenoid biosynthetic process (GO:0008299) | 4.71805224 |
| 16 | cysteine metabolic process (GO:0006534) | 4.66514732 |
| 17 | acetyl-CoA metabolic process (GO:0006084) | 4.65872846 |
| 18 | very long-chain fatty acid metabolic process (GO:0000038) | 4.56733173 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.54919075 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.54919075 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.54919075 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.48450013 |
| 23 | coenzyme catabolic process (GO:0009109) | 4.47058149 |
| 24 | acyl-CoA biosynthetic process (GO:0071616) | 4.41086900 |
| 25 | thioester biosynthetic process (GO:0035384) | 4.41086900 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 4.41046946 |
| 27 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.38990879 |
| 28 | kynurenine metabolic process (GO:0070189) | 4.32103919 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.30707768 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.30639456 |
| 31 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.30379169 |
| 32 | proteasome assembly (GO:0043248) | 4.28767870 |
| 33 | aldehyde catabolic process (GO:0046185) | 4.28461775 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.26095383 |
| 35 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.25385221 |
| 36 | axon ensheathment in central nervous system (GO:0032291) | 4.19619664 |
| 37 | central nervous system myelination (GO:0022010) | 4.19619664 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.19503297 |
| 39 | chaperone-mediated protein transport (GO:0072321) | 4.18753771 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.08416264 |
| 41 | serine family amino acid biosynthetic process (GO:0009070) | 4.07265358 |
| 42 | ethanol oxidation (GO:0006069) | 4.05814790 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.05118030 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 4.05091264 |
| 45 | L-serine metabolic process (GO:0006563) | 4.04840340 |
| 46 | acyl-CoA metabolic process (GO:0006637) | 4.04758815 |
| 47 | thioester metabolic process (GO:0035383) | 4.04758815 |
| 48 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.02759362 |
| 49 | bile acid metabolic process (GO:0008206) | 3.99487188 |
| 50 | low-density lipoprotein particle remodeling (GO:0034374) | 3.88279770 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.87368962 |
| 52 | protein carboxylation (GO:0018214) | 3.85903113 |
| 53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.85903113 |
| 54 | * cholesterol metabolic process (GO:0008203) | 3.85642915 |
| 55 | * steroid biosynthetic process (GO:0006694) | 3.85547399 |
| 56 | short-chain fatty acid metabolic process (GO:0046459) | 3.85087172 |
| 57 | cofactor catabolic process (GO:0051187) | 3.82357947 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80152663 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 3.80152663 |
| 60 | macromolecular complex remodeling (GO:0034367) | 3.80152663 |
| 61 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.78169148 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.76795430 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.76795430 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.75824618 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75227928 |
| 66 | cellular glucuronidation (GO:0052695) | 3.73095420 |
| 67 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70039757 |
| 68 | heme transport (GO:0015886) | 3.68762323 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.68374039 |
| 70 | amine catabolic process (GO:0009310) | 3.68374039 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.65221064 |
| 72 | establishment of integrated proviral latency (GO:0075713) | 3.65043563 |
| 73 | complement activation, alternative pathway (GO:0006957) | 3.62794319 |
| 74 | ketone body metabolic process (GO:1902224) | 3.61488072 |
| 75 | serine family amino acid catabolic process (GO:0009071) | 3.60914960 |
| 76 | * sterol metabolic process (GO:0016125) | 3.59965508 |
| 77 | regulation of protein activation cascade (GO:2000257) | 3.59404322 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.58788943 |
| 79 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.57572349 |
| 80 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.57356867 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.57122815 |
| 82 | urea cycle (GO:0000050) | 3.55858580 |
| 83 | urea metabolic process (GO:0019627) | 3.55858580 |
| 84 | mitotic metaphase plate congression (GO:0007080) | 3.53742162 |
| 85 | glucuronate metabolic process (GO:0019585) | 3.53621597 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.53621597 |
| 87 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.52727561 |
| 88 | glutamate metabolic process (GO:0006536) | 3.51425164 |
| 89 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.50658450 |
| 90 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.48831157 |
| 91 | negative regulation of ligase activity (GO:0051352) | 3.48831157 |
| 92 | regulation of cholesterol metabolic process (GO:0090181) | 3.46544125 |
| 93 | homocysteine metabolic process (GO:0050667) | 3.44130362 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 3.43802051 |
| 95 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.40165664 |
| 96 | cellular amino acid catabolic process (GO:0009063) | 3.40102890 |
| 97 | ethanol metabolic process (GO:0006067) | 3.39326002 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 3.35752283 |
| 99 | cholesterol efflux (GO:0033344) | 3.35217608 |
| 100 | negative regulation of cholesterol transport (GO:0032375) | 3.35079166 |
| 101 | negative regulation of sterol transport (GO:0032372) | 3.35079166 |
| 102 | regulation of triglyceride catabolic process (GO:0010896) | 3.33484429 |
| 103 | regulation of complement activation (GO:0030449) | 3.32799383 |
| 104 | nitrogen cycle metabolic process (GO:0071941) | 3.31866530 |
| 105 | linoleic acid metabolic process (GO:0043651) | 3.27316685 |
| 106 | amino-acid betaine metabolic process (GO:0006577) | 3.27123935 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 3.25017081 |
| 108 | nucleobase catabolic process (GO:0046113) | 3.24627195 |
| 109 | establishment of viral latency (GO:0019043) | 3.20343968 |
| 110 | coenzyme A metabolic process (GO:0015936) | 3.20240849 |
| 111 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.19558972 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.19491749 |
| 113 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.19146719 |
| 114 | arginine metabolic process (GO:0006525) | 3.18784189 |
| 115 | cellular response to cholesterol (GO:0071397) | 3.18058736 |
| 116 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.16555121 |
| 117 | termination of RNA polymerase III transcription (GO:0006386) | 3.16555121 |
| 118 | response to nitrosative stress (GO:0051409) | 3.15917564 |
| 119 | lysine metabolic process (GO:0006553) | 3.15908688 |
| 120 | lysine catabolic process (GO:0006554) | 3.15908688 |
| 121 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.12969492 |
| 122 | DNA damage response, detection of DNA damage (GO:0042769) | 3.11210366 |
| 123 | regulation of mitochondrial translation (GO:0070129) | 3.10880062 |
| 124 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10341393 |
| 125 | DNA strand elongation (GO:0022616) | 3.09917481 |
| 126 | respiratory electron transport chain (GO:0022904) | 3.08583128 |
| 127 | protein maturation by protein folding (GO:0022417) | 3.06146906 |
| 128 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05122084 |
| 129 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05122084 |
| 130 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.05056129 |
| 131 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.05056129 |
| 132 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.05056129 |
| 133 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.03235370 |
| 134 | metaphase plate congression (GO:0051310) | 3.02877771 |
| 135 | DNA replication checkpoint (GO:0000076) | 3.02664252 |
| 136 | electron transport chain (GO:0022900) | 3.00970316 |
| 137 | chromatin remodeling at centromere (GO:0031055) | 3.00304290 |
| 138 | CENP-A containing nucleosome assembly (GO:0034080) | 2.98818764 |
| 139 | positive regulation of ligase activity (GO:0051351) | 2.98815433 |
| 140 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.98678802 |
| 141 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.98678802 |
| 142 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.97671383 |
| 143 | protein targeting to mitochondrion (GO:0006626) | 2.94565967 |
| 144 | spliceosomal snRNP assembly (GO:0000387) | 2.93479533 |
| 145 | purine nucleobase biosynthetic process (GO:0009113) | 2.93021603 |
| 146 | cullin deneddylation (GO:0010388) | 2.87955946 |
| 147 | rRNA modification (GO:0000154) | 2.87039346 |
| 148 | inner mitochondrial membrane organization (GO:0007007) | 2.85502775 |
| 149 | formation of translation preinitiation complex (GO:0001731) | 2.83808247 |
| 150 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.83281246 |
| 151 | protein neddylation (GO:0045116) | 2.82097510 |
| 152 | protein localization to mitochondrion (GO:0070585) | 2.79838817 |
| 153 | ribosomal large subunit biogenesis (GO:0042273) | 2.78095791 |
| 154 | nucleobase biosynthetic process (GO:0046112) | 2.76244633 |
| 155 | tRNA aminoacylation for protein translation (GO:0006418) | 2.75511873 |
| 156 | establishment of protein localization to mitochondrion (GO:0072655) | 2.73392480 |
| 157 | regulation of cellular amine metabolic process (GO:0033238) | 2.72721069 |
| 158 | regulation of ligase activity (GO:0051340) | 2.72630984 |
| 159 | protein deneddylation (GO:0000338) | 2.72006745 |
| 160 | protein complex biogenesis (GO:0070271) | 2.71831345 |
| 161 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.71575997 |
| 162 | NADH dehydrogenase complex assembly (GO:0010257) | 2.71575997 |
| 163 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.71575997 |
| 164 | maturation of SSU-rRNA (GO:0030490) | 2.71339543 |
| 165 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.70890863 |
| 166 | amino acid activation (GO:0043038) | 2.68678240 |
| 167 | tRNA aminoacylation (GO:0043039) | 2.68678240 |
| 168 | 7-methylguanosine mRNA capping (GO:0006370) | 2.61591738 |
| 169 | tricarboxylic acid cycle (GO:0006099) | 2.57476668 |
| 170 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.54636409 |
| 171 | protein localization to kinetochore (GO:0034501) | 2.53714478 |
| 172 | de novo protein folding (GO:0006458) | 2.53469085 |
| 173 | pentose metabolic process (GO:0019321) | 2.53455955 |
| 174 | 7-methylguanosine RNA capping (GO:0009452) | 2.52911757 |
| 175 | RNA capping (GO:0036260) | 2.52911757 |
| 176 | de novo posttranslational protein folding (GO:0051084) | 2.51580510 |
| 177 | ribosomal small subunit assembly (GO:0000028) | 2.49600863 |
| 178 | mitotic sister chromatid segregation (GO:0000070) | 2.49000378 |
| 179 | translation (GO:0006412) | 2.48847200 |
| 180 | cellular component biogenesis (GO:0044085) | 2.47362167 |
| 181 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.46363830 |
| 182 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.45423038 |
| 183 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.44586373 |
| 184 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.44328127 |
| 185 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.44196017 |
| 186 | cell cycle G1/S phase transition (GO:0044843) | 2.44187151 |
| 187 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.44187151 |
| 188 | histone exchange (GO:0043486) | 2.43998008 |
| 189 | ribosome assembly (GO:0042255) | 2.43549040 |
| 190 | ribosomal small subunit biogenesis (GO:0042274) | 2.42641825 |
| 191 | negative regulation of protein ubiquitination (GO:0031397) | 2.41543643 |
| 192 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.40619301 |
| 193 | IMP biosynthetic process (GO:0006188) | 2.40016950 |
| 194 | ribosome biogenesis (GO:0042254) | 2.39532728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.02725434 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06023572 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.12708307 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.91796003 |
| 5 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.79001500 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.78200369 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.67157503 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.54433864 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.96522134 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.95219545 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.84657504 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.77819264 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.52787465 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.39275108 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.37874899 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.23587895 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.16218877 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05805762 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.92064367 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.86541262 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77286077 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.73350048 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69022220 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.59447709 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.55219023 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.51725003 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.50014723 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.45707810 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.44859174 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.37226667 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37147669 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.36419558 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20193405 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.16143174 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15151209 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.13393817 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.12824401 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11898440 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00016714 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93049852 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.92953477 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.89652400 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88967427 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.87451124 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84758092 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81613879 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80329030 |
| 48 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.80068336 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77032909 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74979208 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.73936386 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71069100 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.70269117 |
| 54 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.66928374 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66319115 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66106104 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64052984 |
| 58 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.63787505 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61048294 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61048294 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60180549 |
| 62 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58439044 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58422381 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57130126 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56996095 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53733941 |
| 67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.51751132 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51284693 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.48963186 |
| 70 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.48805447 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47639270 |
| 72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.43557443 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42634176 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39316650 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35905391 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34506844 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27802815 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.27710584 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25902701 |
| 80 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23999031 |
| 81 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23688174 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23422470 |
| 83 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22597449 |
| 84 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.20544727 |
| 85 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20386367 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19726445 |
| 87 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.19330077 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18982104 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18159569 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16178904 |
| 91 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15532519 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15445705 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13839350 |
| 94 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12889192 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12589392 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12159433 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11917323 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07238925 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07224924 |
| 100 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.06748874 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05833218 |
| 102 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05475268 |
| 103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03021363 |
| 104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02517784 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01114559 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00661102 |
| 107 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00439910 |
| 108 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99140133 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98954397 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97977632 |
| 111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97802868 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96971075 |
| 113 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96701924 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96649892 |
| 115 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96001716 |
| 116 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95629503 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95117975 |
| 118 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93569630 |
| 119 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93055938 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92981000 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92866148 |
| 122 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.92776002 |
| 123 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.91599237 |
| 124 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.91328943 |
| 125 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91218819 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89499983 |
| 127 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89215922 |
| 128 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.88941289 |
| 129 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.88204707 |
| 130 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88198099 |
| 131 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87695910 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87611209 |
| 133 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87520110 |
| 134 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87014482 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86163779 |
| 136 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.84492167 |
| 137 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.84247715 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82517302 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82012694 |
| 140 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81604530 |
| 141 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81308821 |
| 142 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80467744 |
| 143 | FUS_26573619_Chip-Seq_HEK293_Human | 0.80322074 |
| 144 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.80245118 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80157237 |
| 146 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79211707 |
| 147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79125472 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77068053 |
| 149 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76871621 |
| 150 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75596762 |
| 151 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.75523147 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75350486 |
| 153 | NCOR_22424771_ChIP-Seq_293T_Human | 0.74210503 |
| 154 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73374220 |
| 155 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.72916394 |
| 156 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71602570 |
| 157 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71465026 |
| 158 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.71214650 |
| 159 | JUN_21703547_ChIP-Seq_K562_Human | 0.70971594 |
| 160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.70686627 |
| 161 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.70686627 |
| 162 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.70400153 |
| 163 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.69361996 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.68913795 |
| 165 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.67958449 |
| 166 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.67418547 |
| 167 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67395073 |
| 168 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66593343 |
| 169 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.66531892 |
| 170 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65304753 |
| 171 | VDR_22108803_ChIP-Seq_LS180_Human | 0.65012841 |
| 172 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.64821758 |
| 173 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.63865680 |
| 174 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.63430787 |
| 175 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.63179896 |
| 176 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62265101 |
| 177 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.61870605 |
| 178 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.61114293 |
| 179 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60645122 |
| 180 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.60420710 |
| 181 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.60220248 |
| 182 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60150383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.25842115 |
| 2 | MP0005360_urolithiasis | 6.34298772 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.98579281 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.61594866 |
| 5 | MP0005365_abnormal_bile_salt | 4.54786508 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.24152302 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.25319503 |
| 8 | MP0005083_abnormal_biliary_tract | 3.23757535 |
| 9 | MP0009840_abnormal_foam_cell | 3.18881920 |
| 10 | MP0005332_abnormal_amino_acid | 2.71071961 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.68761570 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.68406046 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.64486353 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.60033115 |
| 15 | MP0008058_abnormal_DNA_repair | 2.58473471 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.57692329 |
| 17 | MP0003941_abnormal_skin_development | 2.48886410 |
| 18 | MP0003252_abnormal_bile_duct | 2.46362290 |
| 19 | MP0003195_calcinosis | 2.41968158 |
| 20 | MP0003329_amyloid_beta_deposits | 2.41724546 |
| 21 | MP0003111_abnormal_nucleus_morphology | 2.31904265 |
| 22 | MP0010094_abnormal_chromosome_stability | 2.28349292 |
| 23 | MP0003011_delayed_dark_adaptation | 2.27944728 |
| 24 | MP0008789_abnormal_olfactory_epithelium | 2.06219485 |
| 25 | MP0003077_abnormal_cell_cycle | 2.01984644 |
| 26 | MP0003690_abnormal_glial_cell | 1.99281727 |
| 27 | MP0000920_abnormal_myelination | 1.97861361 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.90109247 |
| 29 | MP0009697_abnormal_copulation | 1.88213065 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.88195297 |
| 31 | MP0000604_amyloidosis | 1.77343135 |
| 32 | MP0001529_abnormal_vocalization | 1.77266004 |
| 33 | MP0005451_abnormal_body_composition | 1.72991782 |
| 34 | MP0005408_hypopigmentation | 1.71189499 |
| 35 | MP0003136_yellow_coat_color | 1.69949230 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.66266839 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.60840978 |
| 38 | MP0005499_abnormal_olfactory_system | 1.60840978 |
| 39 | MP0003186_abnormal_redox_activity | 1.60360480 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60055745 |
| 41 | MP0001293_anophthalmia | 1.59582969 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.53723033 |
| 43 | * MP0002938_white_spotting | 1.52270545 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.47714187 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 1.46852788 |
| 46 | MP0000609_abnormal_liver_physiology | 1.46037719 |
| 47 | MP0002233_abnormal_nose_morphology | 1.42830333 |
| 48 | MP0003786_premature_aging | 1.41372887 |
| 49 | MP0003868_abnormal_feces_composition | 1.40272955 |
| 50 | MP0003122_maternal_imprinting | 1.39120323 |
| 51 | MP0003315_abnormal_perineum_morphology | 1.38291454 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.37343060 |
| 53 | MP0003937_abnormal_limbs/digits/tail_de | 1.31053256 |
| 54 | MP0001730_embryonic_growth_arrest | 1.29747946 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.29278601 |
| 56 | MP0004272_abnormal_basement_membrane | 1.28801587 |
| 57 | MP0002697_abnormal_eye_size | 1.27471414 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.25901056 |
| 59 | MP0004133_heterotaxia | 1.25522242 |
| 60 | MP0001905_abnormal_dopamine_level | 1.24403316 |
| 61 | MP0004885_abnormal_endolymph | 1.24168799 |
| 62 | MP0000762_abnormal_tongue_morphology | 1.22510470 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.22493449 |
| 64 | MP0005501_abnormal_skin_physiology | 1.22112326 |
| 65 | MP0001661_extended_life_span | 1.20347506 |
| 66 | MP0005171_absent_coat_pigmentation | 1.17222132 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.15090209 |
| 68 | MP0003121_genomic_imprinting | 1.14195474 |
| 69 | MP0003755_abnormal_palate_morphology | 1.13584956 |
| 70 | MP0000566_synostosis | 1.13332447 |
| 71 | MP0005670_abnormal_white_adipose | 1.12108423 |
| 72 | MP0001764_abnormal_homeostasis | 1.10747940 |
| 73 | MP0000049_abnormal_middle_ear | 1.10196882 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.09056390 |
| 75 | MP0003632_abnormal_nervous_system | 1.08481399 |
| 76 | * MP0002111_abnormal_tail_morphology | 1.05883684 |
| 77 | MP0002084_abnormal_developmental_patter | 1.05862359 |
| 78 | MP0002085_abnormal_embryonic_tissue | 1.05368595 |
| 79 | MP0003942_abnormal_urinary_system | 1.05258278 |
| 80 | MP0002282_abnormal_trachea_morphology | 1.04725357 |
| 81 | MP0000358_abnormal_cell_content/ | 1.04563084 |
| 82 | * MP0005380_embryogenesis_phenotype | 1.03719744 |
| 83 | * MP0001672_abnormal_embryogenesis/_devel | 1.03719744 |
| 84 | MP0003718_maternal_effect | 1.03330470 |
| 85 | MP0000537_abnormal_urethra_morphology | 1.01324958 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.01107145 |
| 87 | MP0003634_abnormal_glial_cell | 1.00592408 |
| 88 | MP0001984_abnormal_olfaction | 0.98721702 |
| 89 | MP0000778_abnormal_nervous_system | 0.98715268 |
| 90 | MP0003123_paternal_imprinting | 0.97903731 |
| 91 | MP0000647_abnormal_sebaceous_gland | 0.97731167 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.96246068 |
| 93 | * MP0001697_abnormal_embryo_size | 0.95877644 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.94794669 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.94515586 |
| 96 | * MP0002080_prenatal_lethality | 0.94166319 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.93561298 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.91833957 |
| 99 | MP0001286_abnormal_eye_development | 0.91822894 |
| 100 | MP0003119_abnormal_digestive_system | 0.91388975 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88783350 |
| 102 | MP0006276_abnormal_autonomic_nervous | 0.88250560 |
| 103 | MP0004142_abnormal_muscle_tone | 0.87600048 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.84544629 |
| 105 | MP0002210_abnormal_sex_determination | 0.84278525 |
| 106 | MP0001849_ear_inflammation | 0.83773661 |
| 107 | MP0001881_abnormal_mammary_gland | 0.81629039 |
| 108 | * MP0003984_embryonic_growth_retardation | 0.81459248 |
| 109 | MP0001542_abnormal_bone_strength | 0.81372805 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.81023645 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.80853441 |
| 112 | * MP0002088_abnormal_embryonic_growth/wei | 0.79119804 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.79026986 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.78701511 |
| 115 | MP0004381_abnormal_hair_follicle | 0.78168120 |
| 116 | MP0003385_abnormal_body_wall | 0.78157953 |
| 117 | MP0002796_impaired_skin_barrier | 0.76238731 |
| 118 | MP0005647_abnormal_sex_gland | 0.76123466 |
| 119 | MP0004270_analgesia | 0.75997395 |
| 120 | MP0002092_abnormal_eye_morphology | 0.75721105 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.74537521 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.74387044 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.72622299 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.72616324 |
| 125 | MP0003938_abnormal_ear_development | 0.69756188 |
| 126 | MP0002160_abnormal_reproductive_system | 0.69493843 |
| 127 | MP0000598_abnormal_liver_morphology | 0.69001940 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.68286732 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.67855536 |
| 130 | MP0002736_abnormal_nociception_after | 0.67366541 |
| 131 | MP0000462_abnormal_digestive_system | 0.66900438 |
| 132 | MP0003631_nervous_system_phenotype | 0.66693501 |
| 133 | MP0003861_abnormal_nervous_system | 0.65940890 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.65756523 |
| 135 | MP0000579_abnormal_nail_morphology | 0.65597773 |
| 136 | MP0005391_vision/eye_phenotype | 0.65394213 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.64352637 |
| 138 | MP0001929_abnormal_gametogenesis | 0.64261638 |
| 139 | MP0001177_atelectasis | 0.63431450 |
| 140 | MP0001243_abnormal_dermal_layer | 0.63160869 |
| 141 | MP0005395_other_phenotype | 0.59134475 |
| 142 | MP0009053_abnormal_anal_canal | 0.59122368 |
| 143 | MP0009763_increased_sensitivity_to | 0.57121567 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.56413872 |
| 145 | MP0001486_abnormal_startle_reflex | 0.55793337 |
| 146 | MP0009764_decreased_sensitivity_to | 0.53920891 |
| 147 | MP0002090_abnormal_vision | 0.53728676 |
| 148 | MP0001346_abnormal_lacrimal_gland | 0.51564769 |
| 149 | MP0002254_reproductive_system_inflammat | 0.50855778 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.50854781 |
| 151 | MP0002229_neurodegeneration | 0.50725500 |
| 152 | MP0005197_abnormal_uvea_morphology | 0.50515016 |
| 153 | MP0004134_abnormal_chest_morphology | 0.50074079 |
| 154 | MP0002971_abnormal_brown_adipose | 0.49977974 |
| 155 | MP0002733_abnormal_thermal_nociception | 0.49655958 |
| 156 | MP0004883_abnormal_blood_vessel | 0.48618615 |
| 157 | MP0001340_abnormal_eyelid_morphology | 0.48072962 |
| 158 | MP0009672_abnormal_birth_weight | 0.47710602 |
| 159 | MP0005535_abnormal_body_temperature | 0.45863632 |
| 160 | MP0005058_abnormal_lysosome_morphology | 0.43943459 |
| 161 | MP0004924_abnormal_behavior | 0.43693290 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.43693290 |
| 163 | MP0005551_abnormal_eye_electrophysiolog | 0.43559490 |
| 164 | MP0005334_abnormal_fat_pad | 0.43243946 |
| 165 | MP0005248_abnormal_Harderian_gland | 0.43179518 |
| 166 | MP0005195_abnormal_posterior_eye | 0.42858024 |
| 167 | MP0005164_abnormal_response_to | 0.42192241 |
| 168 | MP0004858_abnormal_nervous_system | 0.41852002 |
| 169 | MP0004185_abnormal_adipocyte_glucose | 0.41427983 |
| 170 | MP0005266_abnormal_metabolism | 0.40898212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.07846058 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.93246492 |
| 3 | Xanthomatosis (HP:0000991) | 5.47114682 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.44700514 |
| 5 | Abnormality of glycolysis (HP:0004366) | 4.93157887 |
| 6 | Increased serum pyruvate (HP:0003542) | 4.93157887 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.89130715 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.55017058 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.49827962 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.42258934 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.29465283 |
| 12 | Epidermoid cyst (HP:0200040) | 3.93565855 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 3.87301692 |
| 14 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74349113 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64452387 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.64452387 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.51892087 |
| 18 | Hyperglycinemia (HP:0002154) | 3.50967910 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47861774 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.36146719 |
| 21 | Fat malabsorption (HP:0002630) | 3.33330598 |
| 22 | Hyperammonemia (HP:0001987) | 3.27922267 |
| 23 | Complement deficiency (HP:0004431) | 3.24865735 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.23099465 |
| 25 | Increased CSF lactate (HP:0002490) | 3.14892915 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.08242553 |
| 27 | Ketosis (HP:0001946) | 2.97902371 |
| 28 | Hyperglycinuria (HP:0003108) | 2.92093339 |
| 29 | Hepatocellular necrosis (HP:0001404) | 2.89815949 |
| 30 | Cerebral edema (HP:0002181) | 2.88677414 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86684226 |
| 32 | Steatorrhea (HP:0002570) | 2.86076561 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.83092501 |
| 34 | Spastic paraparesis (HP:0002313) | 2.80052020 |
| 35 | Hypophosphatemic rickets (HP:0004912) | 2.73318962 |
| 36 | Acute encephalopathy (HP:0006846) | 2.68934930 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.67975770 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.65263133 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.63481484 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.62770816 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.61659752 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.60260699 |
| 43 | Joint hemorrhage (HP:0005261) | 2.60236080 |
| 44 | Cortical dysplasia (HP:0002539) | 2.59578377 |
| 45 | Cholecystitis (HP:0001082) | 2.56768247 |
| 46 | Abnormal gallbladder physiology (HP:0012438) | 2.56768247 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.56249668 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.51845510 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.48984502 |
| 50 | Lethargy (HP:0001254) | 2.48640602 |
| 51 | Acanthocytosis (HP:0001927) | 2.46585622 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.45989679 |
| 53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45681437 |
| 54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45681437 |
| 55 | Increased serum lactate (HP:0002151) | 2.42859870 |
| 56 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41258342 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.39622369 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.39622369 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.38008992 |
| 60 | Opisthotonus (HP:0002179) | 2.37283954 |
| 61 | Sparse eyelashes (HP:0000653) | 2.35849551 |
| 62 | Skin nodule (HP:0200036) | 2.33919280 |
| 63 | Multiple enchondromatosis (HP:0005701) | 2.33112583 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.31223127 |
| 65 | Abnormality of the corticospinal tract (HP:0002492) | 2.30248350 |
| 66 | Fragile nails (HP:0001808) | 2.28985803 |
| 67 | Lactic acidosis (HP:0003128) | 2.28415042 |
| 68 | Vascular calcification (HP:0004934) | 2.28117153 |
| 69 | Leukodystrophy (HP:0002415) | 2.27247644 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26169738 |
| 71 | Abnormal lung lobation (HP:0002101) | 2.23048647 |
| 72 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.22350879 |
| 73 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.22350879 |
| 74 | Abnormality of complement system (HP:0005339) | 2.20239357 |
| 75 | Microglossia (HP:0000171) | 2.19922946 |
| 76 | Rickets (HP:0002748) | 2.19627118 |
| 77 | Renal Fanconi syndrome (HP:0001994) | 2.19348931 |
| 78 | Horseshoe kidney (HP:0000085) | 2.18444037 |
| 79 | Acute necrotizing encephalopathy (HP:0006965) | 2.16932034 |
| 80 | Bifid tongue (HP:0010297) | 2.15727691 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.15711311 |
| 82 | Reticulocytopenia (HP:0001896) | 2.15419784 |
| 83 | Microvesicular hepatic steatosis (HP:0001414) | 2.14415323 |
| 84 | Paraparesis (HP:0002385) | 2.13954382 |
| 85 | Insidious onset (HP:0003587) | 2.13334464 |
| 86 | Termporal pattern (HP:0011008) | 2.13334464 |
| 87 | Abnormality of the gallbladder (HP:0005264) | 2.13163460 |
| 88 | Vomiting (HP:0002013) | 2.11297031 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.10855198 |
| 90 | Ketoacidosis (HP:0001993) | 2.10814526 |
| 91 | Exercise intolerance (HP:0003546) | 2.09633354 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09179528 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.09179528 |
| 94 | Nausea (HP:0002018) | 2.08887031 |
| 95 | Oral leukoplakia (HP:0002745) | 2.08514972 |
| 96 | Poor suck (HP:0002033) | 2.08032184 |
| 97 | Synostosis involving the elbow (HP:0003938) | 2.06928335 |
| 98 | Humeroradial synostosis (HP:0003041) | 2.06928335 |
| 99 | Brushfield spots (HP:0001088) | 2.06399055 |
| 100 | Hepatocellular carcinoma (HP:0001402) | 2.04691695 |
| 101 | Metabolic acidosis (HP:0001942) | 2.04662321 |
| 102 | * Parakeratosis (HP:0001036) | 2.04211473 |
| 103 | Amyloidosis (HP:0011034) | 2.04014769 |
| 104 | Coronal craniosynostosis (HP:0004440) | 2.03928491 |
| 105 | Respiratory failure (HP:0002878) | 2.03452812 |
| 106 | Delayed myelination (HP:0012448) | 2.02485667 |
| 107 | Hypoglycemic coma (HP:0001325) | 2.02265401 |
| 108 | Secondary amenorrhea (HP:0000869) | 2.02023459 |
| 109 | Cardiovascular calcification (HP:0011915) | 2.01761325 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 2.00207616 |
| 111 | Glycosuria (HP:0003076) | 2.00207616 |
| 112 | Hypokinesia (HP:0002375) | 1.97438887 |
| 113 | Septate vagina (HP:0001153) | 1.97073024 |
| 114 | Enlarged kidneys (HP:0000105) | 1.96584728 |
| 115 | Methylmalonic aciduria (HP:0012120) | 1.95694044 |
| 116 | * Irritability (HP:0000737) | 1.95472003 |
| 117 | Protuberant abdomen (HP:0001538) | 1.95073154 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 1.94269331 |
| 119 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.92505828 |
| 120 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90637879 |
| 121 | Hepatic necrosis (HP:0002605) | 1.90117407 |
| 122 | Abnormal protein glycosylation (HP:0012346) | 1.89082851 |
| 123 | Abnormal glycosylation (HP:0012345) | 1.89082851 |
| 124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89082851 |
| 125 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.89082851 |
| 126 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88995575 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 1.88203473 |
| 128 | Rough bone trabeculation (HP:0100670) | 1.87840845 |
| 129 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85491356 |
| 130 | Cholelithiasis (HP:0001081) | 1.85048828 |
| 131 | Infantile muscular hypotonia (HP:0008947) | 1.84269956 |
| 132 | Meckel diverticulum (HP:0002245) | 1.84021512 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 1.82696230 |
| 134 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.82358823 |
| 135 | Back pain (HP:0003418) | 1.82114408 |
| 136 | Proximal placement of thumb (HP:0009623) | 1.81916445 |
| 137 | Sclerocornea (HP:0000647) | 1.81384899 |
| 138 | Aplasia involving bones of the extremities (HP:0009825) | 1.80463388 |
| 139 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80463388 |
| 140 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80463388 |
| 141 | Abnormality of the preputium (HP:0100587) | 1.80222229 |
| 142 | Progressive macrocephaly (HP:0004481) | 1.79893635 |
| 143 | Abnormality of abdominal situs (HP:0011620) | 1.79781658 |
| 144 | Abdominal situs inversus (HP:0003363) | 1.79781658 |
| 145 | Sensory axonal neuropathy (HP:0003390) | 1.79322017 |
| 146 | CNS demyelination (HP:0007305) | 1.78360027 |
| 147 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.77871481 |
| 148 | Abnormal number of erythroid precursors (HP:0012131) | 1.77159129 |
| 149 | Chromsome breakage (HP:0040012) | 1.75828799 |
| 150 | Spastic diplegia (HP:0001264) | 1.75803754 |
| 151 | Cerebral hypomyelination (HP:0006808) | 1.75750703 |
| 152 | Macrocytic anemia (HP:0001972) | 1.74310998 |
| 153 | Onycholysis (HP:0001806) | 1.73203615 |
| 154 | Hemivertebrae (HP:0002937) | 1.73006123 |
| 155 | * X-linked dominant inheritance (HP:0001423) | 1.72390855 |
| 156 | Abnormality of the ileum (HP:0001549) | 1.71536791 |
| 157 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.71261441 |
| 158 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.70601465 |
| 159 | Abnormal number of incisors (HP:0011064) | 1.68233812 |
| 160 | Postnatal microcephaly (HP:0005484) | 1.63852389 |
| 161 | Deviation of the thumb (HP:0009603) | 1.63500247 |
| 162 | Facial cleft (HP:0002006) | 1.62729719 |
| 163 | Optic disc pallor (HP:0000543) | 1.62660164 |
| 164 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.62438750 |
| 165 | Abnormality of alanine metabolism (HP:0010916) | 1.62438750 |
| 166 | Hyperalaninemia (HP:0003348) | 1.62438750 |
| 167 | Birth length less than 3rd percentile (HP:0003561) | 1.62039853 |
| 168 | Preaxial hand polydactyly (HP:0001177) | 1.60449249 |
| 169 | 3-Methylglutaconic aciduria (HP:0003535) | 1.59365180 |
| 170 | * Congenital ichthyosiform erythroderma (HP:0007431) | 1.59150318 |
| 171 | Respiratory difficulties (HP:0002880) | 1.58596723 |
| 172 | Hypoplastic female external genitalia (HP:0012815) | 1.58419916 |
| 173 | Abnormality of the labia (HP:0000058) | 1.55861179 |
| 174 | Trismus (HP:0000211) | 1.55692809 |
| 175 | Increased nuchal translucency (HP:0010880) | 1.54023259 |
| 176 | Facial hemangioma (HP:0000329) | 1.53128598 |
| 177 | * Hypoplastic pelvis (HP:0008839) | 1.52394278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.92074813 |
| 2 | BUB1 | 3.71614783 |
| 3 | VRK2 | 3.56089962 |
| 4 | BCR | 3.29329866 |
| 5 | EPHB1 | 3.20522113 |
| 6 | OXSR1 | 3.12103403 |
| 7 | NEK1 | 3.06839382 |
| 8 | PBK | 3.05435104 |
| 9 | LIMK1 | 2.99086799 |
| 10 | EIF2AK1 | 2.91468273 |
| 11 | TESK2 | 2.91024101 |
| 12 | BCKDK | 2.74394319 |
| 13 | MARK1 | 2.69929130 |
| 14 | TRIM28 | 2.66268090 |
| 15 | ERBB4 | 2.62651836 |
| 16 | NME2 | 2.53550255 |
| 17 | TSSK6 | 2.49412892 |
| 18 | WNK4 | 2.39659450 |
| 19 | MET | 2.25777169 |
| 20 | DYRK2 | 2.19592014 |
| 21 | FGFR2 | 2.17760426 |
| 22 | CDC7 | 2.17365632 |
| 23 | TTK | 2.12042864 |
| 24 | PLK4 | 2.01786422 |
| 25 | CSNK1G3 | 1.98657991 |
| 26 | PLK3 | 1.85557905 |
| 27 | PKN1 | 1.82665502 |
| 28 | WEE1 | 1.79991222 |
| 29 | NME1 | 1.75515106 |
| 30 | PDK2 | 1.71278731 |
| 31 | MAP3K12 | 1.67619358 |
| 32 | NTRK1 | 1.65911376 |
| 33 | MAPKAPK5 | 1.58647448 |
| 34 | FGR | 1.58475417 |
| 35 | EPHA2 | 1.54554306 |
| 36 | CSNK1G2 | 1.53356453 |
| 37 | CSNK1G1 | 1.53252944 |
| 38 | CSNK1A1L | 1.50725237 |
| 39 | VRK1 | 1.48043181 |
| 40 | SIK1 | 1.45939353 |
| 41 | PAK4 | 1.45738166 |
| 42 | EIF2AK3 | 1.45266261 |
| 43 | BRSK1 | 1.42804167 |
| 44 | TNIK | 1.41918701 |
| 45 | PLK1 | 1.40683913 |
| 46 | STK16 | 1.35838699 |
| 47 | PNCK | 1.34008703 |
| 48 | PIM2 | 1.30808135 |
| 49 | ABL2 | 1.27497075 |
| 50 | MST1R | 1.25958994 |
| 51 | UHMK1 | 1.25850702 |
| 52 | TAF1 | 1.22202567 |
| 53 | MAPK13 | 1.20760067 |
| 54 | BMPR1B | 1.17059966 |
| 55 | WNK3 | 1.16518742 |
| 56 | NUAK1 | 1.16158520 |
| 57 | ZAK | 1.14887857 |
| 58 | BRSK2 | 1.12833545 |
| 59 | LATS2 | 1.12358682 |
| 60 | MUSK | 1.12186806 |
| 61 | PAK3 | 1.08447071 |
| 62 | AURKB | 1.07051029 |
| 63 | CDK14 | 1.04136525 |
| 64 | FGFR4 | 1.03538311 |
| 65 | MAP2K7 | 1.03462161 |
| 66 | DYRK3 | 1.03354088 |
| 67 | MST4 | 1.02777724 |
| 68 | CHEK2 | 1.02354468 |
| 69 | CASK | 0.99103348 |
| 70 | ROCK2 | 0.97838869 |
| 71 | TAOK3 | 0.91327212 |
| 72 | TESK1 | 0.90503805 |
| 73 | MAPK4 | 0.90328588 |
| 74 | PHKG1 | 0.90253742 |
| 75 | PHKG2 | 0.90253742 |
| 76 | ILK | 0.88791797 |
| 77 | CDK15 | 0.88604232 |
| 78 | SGK223 | 0.88297235 |
| 79 | SGK494 | 0.88297235 |
| 80 | CDK18 | 0.87839916 |
| 81 | PRKCI | 0.86403407 |
| 82 | MAP4K2 | 0.84344559 |
| 83 | MKNK1 | 0.84204484 |
| 84 | BRAF | 0.82535149 |
| 85 | ATR | 0.82276243 |
| 86 | PLK2 | 0.79049995 |
| 87 | CDK11A | 0.78172346 |
| 88 | NEK2 | 0.77616114 |
| 89 | LMTK2 | 0.76241343 |
| 90 | NTRK2 | 0.75939943 |
| 91 | LATS1 | 0.73782130 |
| 92 | CAMK2G | 0.72862728 |
| 93 | PRKCQ | 0.72006408 |
| 94 | EPHB2 | 0.71837105 |
| 95 | MINK1 | 0.70373596 |
| 96 | IRAK2 | 0.70323065 |
| 97 | PRKCZ | 0.69362318 |
| 98 | MAPK12 | 0.69253550 |
| 99 | PAK1 | 0.68754027 |
| 100 | EIF2AK2 | 0.68718924 |
| 101 | MKNK2 | 0.68284569 |
| 102 | CSNK2A1 | 0.67179127 |
| 103 | ERBB2 | 0.66272524 |
| 104 | INSRR | 0.66134278 |
| 105 | CLK1 | 0.65790474 |
| 106 | CDK8 | 0.65181234 |
| 107 | CSNK2A2 | 0.65051999 |
| 108 | CAMK2A | 0.64752183 |
| 109 | CHEK1 | 0.64574899 |
| 110 | CDK7 | 0.63519710 |
| 111 | EPHA4 | 0.62667629 |
| 112 | GSK3A | 0.62549391 |
| 113 | WNK1 | 0.62435156 |
| 114 | LRRK2 | 0.62189915 |
| 115 | CAMK2B | 0.61711152 |
| 116 | MAP2K4 | 0.61386261 |
| 117 | ADRBK1 | 0.60038774 |
| 118 | CDK19 | 0.59612854 |
| 119 | STK38L | 0.58357980 |
| 120 | PRKCE | 0.55544387 |
| 121 | CSNK1E | 0.55491270 |
| 122 | DDR2 | 0.54975716 |
| 123 | ERBB3 | 0.54744175 |
| 124 | IRAK3 | 0.53909205 |
| 125 | AKT2 | 0.53735931 |
| 126 | PIK3CA | 0.52984688 |
| 127 | MYLK | 0.50374444 |
| 128 | STK10 | 0.50202488 |
| 129 | ATM | 0.50130770 |
| 130 | DAPK1 | 0.49666462 |
| 131 | CAMK2D | 0.49525242 |
| 132 | PRKCG | 0.49389836 |
| 133 | MAP3K2 | 0.48552154 |
| 134 | PAK6 | 0.48384111 |
| 135 | IGF1R | 0.47643992 |
| 136 | IRAK1 | 0.47573427 |
| 137 | PRKACG | 0.46848385 |
| 138 | FGFR1 | 0.46716979 |
| 139 | FER | 0.46484488 |
| 140 | MAP3K8 | 0.46286231 |
| 141 | MAP2K1 | 0.45405872 |
| 142 | CDK9 | 0.44775875 |
| 143 | GRK6 | 0.44713929 |
| 144 | BMX | 0.44120030 |
| 145 | GRK5 | 0.42760752 |
| 146 | ROCK1 | 0.42682902 |
| 147 | EPHA3 | 0.42145056 |
| 148 | SMG1 | 0.40754433 |
| 149 | CDK1 | 0.39791202 |
| 150 | FYN | 0.38897954 |
| 151 | CDK5 | 0.38174268 |
| 152 | NEK9 | 0.37975849 |
| 153 | PRKG1 | 0.37566639 |
| 154 | DAPK3 | 0.37429187 |
| 155 | PRKACA | 0.37029323 |
| 156 | MAP3K4 | 0.36912317 |
| 157 | ARAF | 0.35717377 |
| 158 | CCNB1 | 0.34933788 |
| 159 | PRKACB | 0.34231572 |
| 160 | AURKA | 0.33690262 |
| 161 | TRPM7 | 0.33605456 |
| 162 | PTK2 | 0.32750805 |
| 163 | SRPK1 | 0.31657422 |
| 164 | NEK6 | 0.31100905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 4.62150748 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.87223083 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.72576127 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.66736132 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32592779 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.83170675 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.78695162 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50788724 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47309666 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46935111 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46344096 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38176752 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32348094 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.28785905 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26914807 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.22598261 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.20693665 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16537712 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 2.14461670 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.02308093 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 2.00346835 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96612597 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91269009 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87749477 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86925940 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.86240248 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77448261 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77107983 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74324908 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70925395 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69289701 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69047133 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67877882 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63081126 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.59935561 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55210474 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45906755 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.45261534 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44999356 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44919809 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.42897152 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.35298970 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35098674 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29947231 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.29581013 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24866636 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24258027 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21963339 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20579614 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20220323 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18603722 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15660794 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12239903 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10972474 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09121923 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.09090491 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07329076 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03575444 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02478441 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02308054 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01871756 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.99421350 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96920321 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 0.96889716 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93761523 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92875369 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89836236 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88542732 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88241664 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87231196 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86044491 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85988918 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82009974 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80591985 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79375877 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.77366773 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77182965 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75020151 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71677450 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69876135 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65656580 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65115456 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64750879 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.62783619 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62677853 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57816943 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56637180 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54559987 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.54358512 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51125253 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49518210 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48081223 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45409894 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40863245 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.40279506 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39567605 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38671831 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38300964 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37122908 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36371416 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36200772 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.35052443 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.33693556 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30008013 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29892446 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.29493317 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27575120 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26092910 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25568500 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25393227 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24282082 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23073042 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.22586334 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19434680 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17234004 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.15091082 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.12158599 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.10419572 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.01584579 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00909316 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.1862673 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1800423 |
| 123 | Lysosome_Homo sapiens_hsa04142 | -0.1771680 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.1711988 |
| 125 | Malaria_Homo sapiens_hsa05144 | -0.1543959 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.1482617 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1161155 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1120970 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0961198 |
| 130 | Phagosome_Homo sapiens_hsa04145 | -0.0867874 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0791704 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0568107 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | -0.0385066 |

